Ultima HCG 5000IU

Human Chorionic Gonadotropin (HCG) is a significant polypeptide hormone present in pregnant females. Medically, it is utilized primarily for conditions such as cryptorchidism, female infertility, hypogonadism (low testosterone), and weight loss.

Additionally, many users of anabolic steroids incorporate HCG either alongside their steroid regimen or after its cessation. The rationale behind this is to counteract the hormonal suppression caused by steroids during use and to facilitate a more effective recovery afterwards.

One of the main applications of HCG today is as a weight loss aid, commonly known as the HCG diet. This diet has gained significant traction in Western medicine; however, its efficacy is a contentious issue. Both the American Medical Association and the American Society of Bariatric Physicians have criticized the HCG diet, asserting that weight loss is primarily attributed to the extreme caloric restriction associated with it, as the diet typically allows only 500 calories per day. Furthermore, HCG does not stimulate thyroid activity, act as a beta-2 stimulant, suppress appetite, or possess characteristics of a thermogenic or fat-burning agent. Despite some doctors reporting positive outcomes with HCG diets, the adverse implications of such drastic calorie intake lead to criticism, as it is not a sustainable long-term approach. Currently, there is no conclusive evidence indicating that weight loss observed in patients would not have occurred without HCG when adhering to a similar starvation regimen, and the discussion over this diet is likely to persist for years.

For anabolic steroid users, the influence of HCG can be categorized into two main instances: post-cycle therapy (PCT) and during the steroid cycle itself. Anabolic steroid use often suppresses natural testosterone production significantly. The degree of this suppression varies depending on the specific steroids and dosages taken. After stopping all steroid use, natural testosterone levels should eventually resume, though this process is gradual, often resulting in a period of low testosterone that can lead to unwanted symptoms, including muscle loss due to cortisol taking precedence. Therefore, many steroid users opt for a PCT strategy to accelerate recovery and ensure sufficient testosterone levels for proper physiological functioning while natural production ramps back up.

There are various PCT protocols, often incorporating Selective Estrogen Receptor Modulators (SERMs) like Nolvadex (Tamoxifen Citrate) and/or Clomid (Clomiphene Citrate). Many users have found that initiating PCT with HCG before introducing SERM therapy enhances overall recovery. HCG effectively mimics luteinizing hormone (LH), preparing the body for the subsequent SERM treatment, thereby facilitating a more effective recovery.

Another beneficial use of HCG for anabolic steroid users occurs during steroid cycles. The suppression of testosterone production can lead to testicular atrophy. By supplementing with HCG during this period, individuals can maintain testicular size. While this may appear purely cosmetic, there’s a potential advantage: keeping the body supplied with exogenous LH may ease recovery once steroid use is discontinued. However, it is crucial to note that the body can develop a dependency on HCG for its LH supply, unlike steroids; thus, careful regulation of HCG use during cycles is essential. For patients with existing low testosterone, this dependency poses no issue, but non-low testosterone individuals must be cautious to prevent HCG dependency. Misuse of HCG can lead to more significant long-term damage than many anabolic steroids. While judicious use during cycles can aid recovery, it necessitates responsible administration and monitoring.

When considering the use of HCG by anabolic steroid users during cycles, a typical dosage would be 250 iu every 4-5 days, which is usually sufficient to achieve desired results and should not exceed this amount to protect future natural testosterone production.

For PCT, there are two acceptable protocols. The first method requires administering 1,500-4,000 iu every 3-4 days for 2-3 weeks, followed by SERM therapy. The second, potentially more effective approach is to take HCG at 500-1,000 iu daily for ten consecutive days, after which SERM therapy should commence.

Timing is critical when using HCG during PCT. If a steroid cycle ends with larger ester-based steroids, HCG therapy should start ten days after the last injection, followed by SERM therapy upon completion of HCG. Conversely, if the cycle concludes with small ester steroids, HCG therapy should begin three days after the last injection, with SERM therapy starting after HCG concludes.